May 2nd 2025
Collagen structure and vessel density vary by photoaging type, highlighting the value of multimodal imaging in guiding individualized skin care strategies.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Sculptra tips include enforcing 'Rule of Fives,' combining with temporary fillers
September 1st 2006National report - Poly-L-lactic acid filler Sculptra (Dermik) can offer some excellent long-term results in adding volume when patients have facial lipoatrophy, and Cherie Ditre, M.D., offers some key tips to further enhance successful use of the filler.
Clinicians finding multiple uses for new line of topical hyaluronic acid products
September 1st 2006National report - Experience with a new topical product line containing hyaluronic acid sodium salt 0.2 percent (Bionect, JSJ Pharmaceuticals) indicates it may be useful for optimizing the healing environment when the skin barrier has been disrupted by various dermatologic treatments.
Total body photography not standard of care
September 1st 2006Eckley M. Keach's article in the June 2006 issue of Dermatology Times ("Successful malpractice defense lies in body of evidence") provides tips for dermatologists to reduce the risk of malpractice liability from treating high-risk melanoma patients.
Cosmeceuticals may help some of the time, but jury is out on wrinkles
August 1st 2006Scottsdale, Ariz. - For dermatologists interested in the in-office dispensing of cosmeceuticals, three agents in particular - ferulic acid, idebenone and human growth factors - are gaining prominence, but is there evidence to back them up?
Ron Reagan pleads for support for stem cell research
July 29th 2006Stem cell research is among the "one or two paradigm-changing medical breakthroughs" that may occur in a lifetime, and it's vitally needed to bring hope to millions, says Ron Reagan, son of the late President Ronald Reagan. Mr. Reagan addressed the Friday morning plenary session at the American Academy of Dermatology's Academy '06, couching in impassioned and often stinging political commentary his plea for support for stem cell research.
Immune response modifier post-op
July 1st 2006San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.